CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
46.30
-0.68 (-1.45%)
At close: Jul 31, 2026, 4:00 PM EDT
46.05
-0.25 (-0.54%)
After-hours: Jul 31, 2026, 7:34 PM EDT
CONMED Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,372 | 1,375 | 1,307 | 1,245 | 1,045 | 1,011 |
Revenue Growth | 3.42% | 5.18% | 5.00% | 19.06% | 3.45% | 17.18% |
Gross Profit Gross Profit Growth | 765.31 | 750.48 | 733.03 | 676.25 | 571.25 | 568.04 |
Operating Income Operating Income Growth | 110.32 | 102.2 | 200.33 | 120.6 | -41.96 | 108.59 |
Net Income Net Income Growth | 56.5 | 47.06 | 132.42 | 64.46 | -80.58 | 62.54 |
Earnings Per Share EPS Growth | 1.85 | 1.51 | 4.25 | 2.04 | -2.68 | 1.94 |
EPS Growth | -47.59% | -64.47% | 108.33% | - | - | 506.25% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Orthopedic Surgery Orthopedic Surgery Growth | 595.55 | 574.6 | 543.99 | 533.16 | 461.53 | 438.42 |
General Surgery General Surgery Growth | 776.11 | 800.13 | 763.03 | 711.59 | 583.94 | 572.21 |
Revenue (Total) Revenue (Total) Growth | 1,372 | 1,375 | 1,307 | 1,245 | 1,045 | 1,011 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 37.33 | 40.82 | 24.46 | 24.3 | 28.94 | 20.85 |
Total Debt Total Debt Growth | 834.25 | 834.94 | 905.78 | 973.85 | 1,055 | 684.66 |
Net Cash (Debt) Net Cash Growth | -796.92 | -794.13 | -881.32 | -949.55 | -1,026 | -663.81 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -25.95 | -25.49 | -28.29 | -30.10 | -34.15 | -20.60 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 150.59 | 170.69 | 166.97 | 125.35 | 33.37 | 111.77 |
Capital Expenditures CapEx Growth | -16.12 | -19.81 | -13.08 | -19.03 | -21.79 | -14.87 |
Free Cash Flow Free Cash Flow Growth | 134.46 | 150.88 | 153.88 | 106.32 | 11.58 | 96.9 |
Free Cash Flow Growth | -9.29% | -1.95% | 44.74% | 818.10% | -88.05% | 88.10% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 55.79% | 54.59% | 56.08% | 54.33% | 54.64% | 56.21% |
Operating Margin | 8.04% | 7.43% | 15.33% | 9.69% | -4.01% | 10.74% |
Pretax Margin | 5.86% | 5.17% | 12.47% | 6.49% | -6.78% | 7.23% |
Profit Margin | 3.91% | 3.42% | 10.13% | 5.18% | -7.71% | 6.19% |
FCF Margin | 9.80% | 10.98% | 11.77% | 8.54% | 1.11% | 9.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.600 | 0.800 | 0.800 | 0.800 | 0.800 |
Dividend Per Share Growth | 0% | -25.00% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.43% | 1.96% | 1.17% | 0.73% | 0.90% | 0.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.15 | 26.89 | 16.10 | 53.68 | - | 73.07 |
Forward PE | 10.33 | 9.42 | 14.72 | 26.27 | 28.25 | 40.05 |
P/FCF Ratio | 10.31 | 8.33 | 13.75 | 31.69 | 233.37 | 42.97 |
PS Ratio | 1.01 | 0.91 | 1.62 | 2.71 | 2.58 | 4.12 |